BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Nuclear receptor subfamily 4 group A member 1 (NR4A1, NGFI-B, NURR77)

March 5, 2015 8:00 AM UTC

Mouse studies suggest NR4A1 agonists could help treat multiple types of fibrosis. In a mouse model of transforming growth factor (TGF)-β-driven skin fibrosis, NR4A1 knockout increased expression of pr...